Insider · CIK 0001397329

Berrey M Michelle

Reports to the SEC for 4 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001397329

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	President, R&D and CMO	DDisposition to Issuer	−93K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	President, R&D and CMO	DDisposition to Issuer	−17.6K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.D Disposition to Issuer	President, R&D and CMO	DDisposition to Issuer	−51.8K sh	$19.00	−$984K	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.U Disposition from Tender	President, R&D and CMO	UDisposition from Tender	−28.3K sh	$19.00	−$539K	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	President, R&D and CMO	DDisposition to Issuer	−24K sh	—	—	0
2023-09-14	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	President, R&D and CMO	FTax Payment	−1,246 sh	$11.57	−$14.4K	80,139
2023-06-14	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	President, R&D and CMO	FTax Payment	−1,246 sh	$12.04	−$15K	81,385
2023-03-14	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	President, R&D and CMO	FTax Payment	−1,246 sh	$15.79	−$19.7K	82,631
2023-02-15	OCEAOcean Biomedical, Inc. · Stock Option (right to buy)A Award	Director	AAward	+75K sh	—	—	75,000
2023-01-27	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	President, R&D and CMO	AAward	+24K sh	—	—	24,000
2023-01-27	INTERCEPT PHARMACEUTICALS, INC.A Award	President, R&D and CMO	AAward	+14.7K sh	—	—	83,877
2022-12-31	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	President, R&D and CMO	FTax Payment	−765 sh	$12.37	−$9,463.05	69,177
2022-12-14	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	President, R&D and CMO	FTax Payment	−1,246 sh	$14.94	−$18.6K	69,942
2022-09-14	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	President, R&D and CMO	FTax Payment	−1,246 sh	$17.14	−$21.4K	71,188
2022-06-14	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	President, R&D and CMO	FTax Payment	−4,984 sh	$12.10	−$60.3K	72,434
2022-01-27	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	President, R&D and CMO	AAward	+17.6K sh	—	—	17,600
2022-01-27	INTERCEPT PHARMACEUTICALS, INC.A Award	President, R&D and CMO	AAward	+10.3K sh	—	—	77,418
2021-06-14	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	President, R&D and CMO	AAward	+93K sh	—	—	93,000
2021-06-14	INTERCEPT PHARMACEUTICALS, INC.A Award	President, R&D and CMO	AAward	+67.1K sh	—	—	67,118
2019-01-23	CHIMERIX INCStock Option (Right to Buy)A Award	Director, President and CEO	AAward	+400K sh	—	—	400,000
2018-06-12	CHIMERIX INCP Purchase	Director, President and CEO	PPurchase	+10K sh	$4.50	+$45K	99,685
2018-05-08	CHIMERIX INCStock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−11.3K sh	—	—	15,161
2018-05-08	CHIMERIX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+11.3K sh	$4.26	+$47.9K	325,256
2018-03-06	CHIMERIX INCStock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10.1K sh	—	—	26,411
2018-03-06	CHIMERIX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10.1K sh	$4.26	+$42.9K	311,336
2018-01-25	CHIMERIX INCStock Option (Right to Buy)A Award	Director, President and CEO	AAward	+400K sh	—	—	400,000
2017-06-21	CHIMERIX INCStock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−23.5K sh	—	—	36,482
2017-06-21	CHIMERIX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+23.5K sh	$4.26	+$100K	323,947
2017-03-10	CHIMERIX INCA Award	Director, President and CEO	AAward	+4,523 sh	$4.10	+$18.5K	366,684
2017-01-24	CHIMERIX INCStock Option (Right to Buy)A Award	Director, President and CEO	AAward	+148K sh	—	—	148,000
2017-01-24	CHIMERIX INCA Award	Director, President and CEO	AAward	+74K sh	—	—	362,161
2016-11-29	CHIMERIX INCStock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−2,400 sh	—	—	59,956
2016-11-29	CHIMERIX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+2,400 sh	$4.26	+$10.2K	288,161
2016-09-09	CHIMERIX INCA Award	Director, President and CEO	AAward	+4,523 sh	$4.05	+$18.3K	285,761
2016-08-29	CHIMERIX INCP Purchase	Director, President and CEO	PPurchase	+22.4K sh	$4.47	+$100K	281,238
2016-06-24	CHIMERIX INCP Purchase	Director, President and CEO	PPurchase	+13.2K sh	$3.69	+$48.6K	258,821
2016-05-09	CHIMERIX INCA Award	Director, President and CEO	AAward	+100K sh	—	—	245,633
2016-03-01	CHIMERIX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+11K sh	$4.26	+$46.9K	145,633
2016-03-01	CHIMERIX INCStock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−11K sh	—	—	62,356
2016-01-08	CHIMERIX INCStock Option (Right to Buy)A Award	Director, President and CEO	AAward	+484K sh	—	—	483,600
2015-08-26	CHIMERIX INCStock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−2,796 sh	—	—	58,713
2015-08-26	CHIMERIX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+2,796 sh	$18.75	+$52.4K	133,434
2015-03-20	CHIMERIX INCStock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,335 sh	—	—	73,357
2015-03-20	CHIMERIX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+5,591 sh	$18.75	+$105K	130,638
2015-03-20	CHIMERIX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,335 sh	$4.26	+$31.2K	125,047
2015-03-20	CHIMERIX INCStock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−5,591 sh	—	—	61,509
2015-01-28	CHIMERIX INCStock Option (Right to Buy)A Award	Director, President and CEO	AAward	+184K sh	—	—	184,200
2015-01-21	CHIMERIX INCStock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−3,668 sh	—	—	80,692
2015-01-21	CHIMERIX INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+3,668 sh	$4.26	+$15.6K	116,282
2014-12-22	CHIMERIX INCStock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−14.7K sh	—	—	84,360

Recent filings

Accepted (ET)
Nov 134
Berrey M Michelle0001104659-23-117115
SEC(opens sec.gov)
Sep 184
Berrey M Michelle0001104659-23-101573
SEC(opens sec.gov)
Jun 164
Berrey M Michelle0001104659-23-072210
SEC(opens sec.gov)
Mar 164
Berrey M Michelle0001104659-23-033307
SEC(opens sec.gov)
Feb 174
Berrey M Michelle0001493152-23-005544
SEC(opens sec.gov)
Jan 314
Berrey M Michelle0001104659-23-008581
SEC(opens sec.gov)
Jan 34
Berrey M Michelle0001104659-23-000327
SEC(opens sec.gov)
Dec 164
Berrey M Michelle0001104659-22-127799
SEC(opens sec.gov)
Sep 164
Berrey M Michelle0001104659-22-100803
SEC(opens sec.gov)
Jun 164
Berrey M Michelle0001104659-22-071868
SEC(opens sec.gov)
Jan 314
Berrey M Michelle0001104659-22-009551
SEC(opens sec.gov)
Jun 154
Berrey M Michelle0001104659-21-081624
SEC(opens sec.gov)
Jan 254
Berrey M Michelle0001209191-19-005356
SEC(opens sec.gov)

Companies

Address

303A COLLEGE ROAD EAST

PRINCETON, NJ, 08540